User's Manual

Table Of Contents
Radical-7 Safety Information, Warnings, and Cautions
www.masimo.com 17 Masimo
Note: If the Radical-7 fails any part of the setup procedures or leakage spot check, remove
the instrument from operation until qualified service personnel have corrected the
situation.
Note: A functional tester cannot be used to assess the accuracy of the Radical-7.
Note: Do not autoclave, pressure sterilize, or gas sterilize the Radical-7.
Note: Do not touch, press, or rub the display panels with abrasive cleaning compounds,
instruments, brushes, rough-surface materials, or bring them into contact with anything
that could scratch the panel.
Note: Do not use petroleum-based or acetone solutions, or other harsh solvents, to clean the
Radical-7. These substances affect the device’s materials and instrument failure can result.
Note: An operator may only perform maintenance procedures specifically described in the
manual. Refer servicing to qualified service personnel trained in the repair of this
equipment.
Note: SatShare signals are ideal simulated waveforms corresponding to the calculated
saturation and pulse rate values and do contain all of the information contained in
physiological waveforms. The multi-parameter patient monitor decodes these signals into
saturation and pulse rate values.
Note: Simultaneous use of SatShare and serial port is not supported.
Note: If the Radical Docking Station is compatible with SafetyNet, Vuelink is not supported.
Use the Radical-7 in accordance with Environmental Specifications section in of this manual.
This device complies with part 15 of the FCC Rules. Operation is subject to the following two
conditions: (1) This device may not cause harmful interference, and (2) this device must
accept any interference received, including interference that may cause undesired operation.
Cleared Use Only: The device and related accessories are cleared by the Food and Drug
Administration (FDA) for noninvasive patient monitoring and may not be used for any
processes, procedures, experiments or any other use for which the device is not intended or
cleared by the FDA, or in any manner inconsistent with the instructions for use or labeling.
Changes or modifications not expressly approved by the party responsible for compliance
could void the user's authority to operate the equipment.
In accordance with international telecommunication requirements, the frequency band of
2.4 GHz and 5.15 to 5.25 Ghz is only for indoor usage to reduce potential for harmful
interference to co-channel mobile satellite systems.
This equipment has been tested and found to comply with the limits for a Class B digital
device, pursuant to part 15 of the FCC Rules. These limits are designed to provide reasonable
protection against harmful interference in a residential installation. This equipment
generates, uses and can radiate radio frequency energy and, if not installed and used in
accordance with the instructions, may cause harmful interference to radio communications.